MedTech News
.................... by Andrew Celentano
Engineered human neurons rebuild damaged spinal cord circuits
Spinal cord injuries affect an estimated 15 to 20 million people worldwide, often causing lasting impairments in movement, sensation and independence. Such injuries can be especially devastating when they occur at the level of the neck, where damaged spinal circuits disrupt signals that control the diaphragm, the main muscle used for breathing.
Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer
BURLINGTON, N.C., Aug. 4, 2026 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the nationwide availability of Roche’s VENTANA® PTEN (SP218) RxDx Assay, the first immunohistochemistry (IHC) companion diagnostic test approved by the U.S. Food and Drug Administration (FDA) to determine PTEN protein loss, also known as PTEN deficiency, in tumors of patients with prostate adenocarcinoma. The assay helps identify patients who may be eligible for treatment with AstraZeneca’s TRUQAP® (capivasertib) in combination with abiraterone acetate and prednisone.
Koning Health Achieves MDSAP Certification
Certification strengthens Koning’s global regulatory foundation as two new Vera Breast CT systems expand patient access in key U.S. markets
Cortechs.ai Expands CE Marking Across AI Imaging Platform for European Market
Cortechs.ai, a San Diego, CA-based provider of AI-powered quantitative imaging solutions, has announced the expansion of its European CE Marking under the European Union Medical Device Regulation (EU MDR) for its latest imaging products.
Tumor-like tissue environments could hold clues to curing HIV
Viral reservoirs in a proxy animal model of HIV share features with immune-suppressive tumors
Tampa General Hospital Deploys Drones for Pre-Hospital Whole Blood Delivery
Drone delivery will cut average blood transport times to under three minutes across a 70-square-mile coverage area in Hillsborough County
Galaxy Therapeutics’ SEAL embolization system gets CE mark
Galaxy Therapeutics, a privately held medical device company focused on the treatment of intracranial aneurysms, today announced that it has received CE mark for its SEAL Embolization System
Skin-like test models could help improve medical devices for people of all skin tones
Many medical devices and wearable health sensors work by shining light into the skin and measuring the signal that returns. These technologies are used in products ranging from pulse oximeters to fitness trackers. However, studies have shown that some optical devices can be less accurate for people with darker skin, raising concerns about health care equity and patient safety. In a recent study reported in the Journal of Biomedical Optics, researchers at the VTT Technical Research Centre of Finland addressed this problem by developing realistic skin-like test models that represent a range of skin tones and include artificial blood vessels with flowing blood-like fluid.